Bingham Private Wealth, Llc
Source: SEC Form 13F · as of Mar 2026Bingham Private Wealth, Llc holds 17 biotech & pharma companies tracked by BioSniper, totaling $12.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$12.1M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 11,925 | $1.7M |
| PMPhilip Morris International Inc | 8,562 | $1.4M |
| ABBVAbbVie Inc. | 6,404 | $1.4M |
| JNJJOHNSON & JOHNSON | 4,319 | $1.1M |
| LLYELI LILLY & Co | 965 | $888K |
| AZNASTRAZENECA PLC | 3,966 | $782K |
| MRKMerck & Co., Inc. | 5,991 | $720K |
| MCKMcKesson Corporation | 743 | $643K |
| AMGNAMGEN INC | 1,492 | $525K |
| PFEPFIZER INC | 18,480 | $519K |
| GMOptec International, Inc. | 6,380 | $475K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,573 | $425K |
| ABTABBOTT LABORATORIES | 3,458 | $355K |
| INSMINSMED Inc | 2,170 | $355K |
| REGNREGENERON PHARMACEUTICALS, INC. | 454 | $351K |
| SNYSanofi | 5,941 | $286K |
| NVONovo Nordisk A/S | 5,621 | $207K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.